Security key
36315X101
Lakefront Biotherapeutics NV - Ordinary shares, no nominal value per share (the "Ordinary Shares") (LKFT)
CUSIP: 36315X101
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Ordinary shares, no nominal value per share (the "Ordinary Shares")
- Total 13F shares
- 31,401,256
- Total 13F value
- $1,087,732,117
- Share change
- -301,814
- Put/Call ratio
- 64%
- SEC-reported price per share
- $34.64
- Number of holders
- 92
- Value change
- -$7,956,750
- Number of buys
- 48
- Number of sells
- 40
- Shares outstanding
- 65,567,327
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
92
Top holders
10
LKFT full security history
Ownership snapshot
Full 13F holder table
Lakefront Biotherapeutics NV SEC filings
Lakefront Biotherapeutics NV company facts
Broader feeds
Ownership snapshot
Top reported holders of LKFT - Lakefront Biotherapeutics NV - Ordinary shares, no nominal value per share (the "Ordinary Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GILEAD SCIENCES, INC.
Disclosed value leader
GILEAD SCIENCES, INC.
Comparable rows
15/15
Latest evidence
24 Jul 2025
13D/G
13F
Lead comparable stake: 30%
13D/G row: GILEAD SCIENCES, INC.
Showing 1-6 of 15 holder rows.
Quick read
GILEAD SCIENCES, INC. leads the comparable SEC ownership view at 30%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GILEAD SCIENCES, INC.'s linked filing trail.
Comparable ownership
Top 5
GILEAD SCIENCES, INC.
30%
EcoR1 Capital, LLC
13%
TANG CAPITAL MANAGEMENT LLC
6.1%
Madison Avenue Partners, LP
2.9%
Prosight Management, LP
2.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. |
13D/G
13F
Company
|
30%
|
$555,786,955
20,981,010 shares
|
$0 | 07 Jan 2025 |
| EcoR1 Capital, LLC |
13D/G
13F
Company
|
13%
|
$243,919,471
8,714,522 shares
|
+$25,507,847 | 24 Jul 2025 |
| TANG CAPITAL MANAGEMENT LLC |
13F
Company
|
6.1%
|
$111,683,207
3,990,111 shares
|
— | 30 Jun 2025 |
| Madison Avenue Partners, LP |
13F
Company
|
2.9%
|
$52,537,538
1,877,011 shares
|
— | 30 Jun 2025 |
| Prosight Management, LP |
13F
Company
|
2.7%
|
$49,644,436
1,773,649 shares
|
— | 30 Jun 2025 |
| FMR LLC |
13F
Company
|
2.4%
|
$43,301,316
1,547,028 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
92
Shares
31,401,256
Rows available
92
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
85
Q3 2025 holders
92
Holder diff
7
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|